Phase
Condition
Prostate Cancer, Early, Recurrent
Prostate Disorders
Prostate Cancer
Treatment
N/AClinical Study ID
Ages 18-75 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Participants is willing and able to give informed consent for participation in thestudy
Male aged 19-75 years.
Diagnosed with oligo-metastatic prostate cancer (1-3 skeletal lesions on bone specificimaging, no visceral metastases).
Locally resectable tumor (clinical/radiological stage T1-T3).
Eastern Cooperative Oncology Group (ECOG) performance status 0-1.
Suitable for radical prostatectomy within 12 months of starting standard care.
Exclusion
Exclusion Criteria:
Contraindications to radical prostatectomy.
Visceral metastases.
Prior radiotherapy to the abdomen/pelvis or to skeletal metastases.
Any systemic therapy of prostate cancer (including standard care) for 12 or moremonths prior to enrollment.
Current involvement in other interventional research.
Study Design
Study Description
Connect with a study center
Zhongshan Hospital, Fudan University
Shanghai, Shanghai 200032
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.